Androgen deprivation therapy and risk of cognitive dysfunction in men with prostate cancer: is there a possible link?

Prostate International - Tập 10 - Trang 68-74 - 2022
Myungsun Shim1, Woo Jin Bang1, Cheol Young Oh1, Yong Seong Lee1, Jin Seon Cho1
1Department of Urology, Hallym University College of Medicine, Hallym University Sacred Heart Hospital, Anyang, Gyeonggi-do, South Korea

Tài liệu tham khảo

McHugh, 2018, Androgen-deprivation therapy, dementia, and cognitive dysfunction in men with prostate cancer: how much smoke and how much fire?, Cancer, 124, 1326, 10.1002/cncr.31153 Liu, 2019, Prostate cancer in Asia: design of a patient registry to inform real-world treatments, outcomes, and quality of life, Prostate Int, 7, 108, 10.1016/j.prnil.2018.12.001 Jones, 2011, Radiotherapy and short-term androgen deprivation for localized prostate cancer, N Engl J Med, 365, 107, 10.1056/NEJMoa1012348 Bolla, 2002, Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial, Lancet, 360, 103, 10.1016/S0140-6736(02)09408-4 Kuykendal, 2013, Guideline-discordant androgen deprivation therapy in localized prostate cancer: patterns of use in the medicare population and cost implications, Ann Oncol, 24, 1338, 10.1093/annonc/mds618 Carrie, 2016, Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial, Lancet Oncol, 17, 747, 10.1016/S1470-2045(16)00111-X Shahinian, 2005, Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma, Cancer, 103, 1615, 10.1002/cncr.20955 Nelson, 2008, Cognitive effects of hormone therapy in men with prostate cancer: a review, Cancer, 113, 1097, 10.1002/cncr.23658 Keating, 2006, Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer, J Clin Oncol, 24, 4448, 10.1200/JCO.2006.06.2497 Cherrier, 2003, The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer, J Urol, 170, 1808 Salminen, 2004, Associations between serum testosterone fall and cognitive function in prostate cancer patients, Clin Canc Res, 10, 7575, 10.1158/1078-0432.CCR-04-0750 Joly, 2006, Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer, J Urol, 176, 2443 Alibhai, 2010, Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancer, J Clin Oncol, 28, 5030, 10.1200/JCO.2010.30.8742 Nead, 2016, Androgen deprivation therapy and future Alzheimer's disease risk, J Clin Oncol, 34, 566, 10.1200/JCO.2015.63.6266 Baik, 2017, Risk of Alzheimer's disease among senior medicare beneficiaries treated with androgen deprivation therapy for prostate cancer, J Clin Oncol, 35, 3401, 10.1200/JCO.2017.72.6109 Jayadevappa, 2019, Association between androgen deprivation therapy use and diagnosis of dementia in men with prostate cancer, JAMA Netw Open, 2, 10.1001/jamanetworkopen.2019.6562 Khosrow-Khavar, 2017, Androgen deprivation therapy and the risk of dementia in patients with prostate cancer, J Clin Oncol, 35, 201, 10.1200/JCO.2016.69.6203 Shim, 2020, Risk of dementia and Parkinson's disease in patients treated with androgen deprivation therapy using gonadotropin-releasing hormone agonist for prostate cancer: a nationwide population-based cohort study, PloS One, 15, 10.1371/journal.pone.0244660 Lehrer, 2018, No relationship of anti-androgens to Alzheimer's disease or cognitive disorder in the MedWatch database, J Alzheimers Dis Rep, 2, 123 Tully, 2019, Risk of dementia and depression in young and middle-aged men presenting with nonmetastatic prostate cancer treated with androgen deprivation therapy, Eur Urol Oncol, S2588–9311, 30129 Chung, 2016, Androgen deprivation therapy did not increase the risk of Alzheimer's and Parkinson's disease in patients with prostate cancer, Andrology, 4, 481, 10.1111/andr.12187 Kao, 2017, No increased risk of dementia in patients receiving androgen deprivation therapy for prostate cancer: a 5-year follow-up study, Asian J Androl, 19, 414, 10.4103/1008-682X.179528 Nead, 2017, Association between androgen deprivation therapy and risk of dementia, JAMA Oncol, 3, 49, 10.1001/jamaoncol.2016.3662 Kim, 2014, Prevalence and trends of dementia in Korea: a systematic review and meta-analysis, J Kor Med Sci, 29, 903, 10.3346/jkms.2014.29.7.903 Launer, 2002, Demonstrating the case that AD is a vascular disease: epidemiologic evidence, Ageing Res Rev, 1, 61, 10.1016/S0047-6374(01)00364-5 Fillit, 2008, Cardiovascular risk factors and dementia, Am J Geriatr Pharmacother, 6, 100, 10.1016/j.amjopharm.2008.06.004 Launer, 1995, The association between midlife blood pressure levels and late-life cognitive function: the Honolulu-Asia Aging Study, J Am Med Assoc, 274, 1846, 10.1001/jama.1995.03530230032026 Ott, 1999, Diabetes mellitus and the risk of dementia: the Rotterdam Study, Neurology, 53, 1937, 10.1212/WNL.53.9.1937 Yaffe, 2004, Diabetes, impaired fasting glucose, and development of cognitive impairment in older women, Neurology, 63, 658, 10.1212/01.WNL.0000134666.64593.BA Luchsinger, 2008, Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective, Eur J Pharmacol, 585, 119, 10.1016/j.ejphar.2008.02.048 Middleton, 2009, Promising strategies for the prevention of dementia, Arch Neurol, 66, 1210, 10.1001/archneurol.2009.201 Kaufman, 2005, The decline of androgen levels in elderly men and its clinical and therapeutic implications, Endocr Rev, 26, 833, 10.1210/er.2004-0013 Manni, 1985, Bioavailability of albumin-bound testosterone, J Clin Endocrinol Metab, 61, 705, 10.1210/jcem-61-4-705 Pardridge, 1986, Serum bioavailability of sex steroid hormones, Clin Endocrinol Metabol, 15, 259, 10.1016/S0300-595X(86)80024-X Rosario, 2009, Age-related changes in serum and brain levels of androgens in male Brown Norway rats, Neuroreport, 20, 1534, 10.1097/WNR.0b013e328331f968 Rosario, 2011, Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease, Neurobiol Aging, 32, 604, 10.1016/j.neurobiolaging.2009.04.008 Huppenbauer, 2005, Gonadal steroid attenuation of developing hamster facial motoneuron loss by axotomy: equal efficacy of testosterone, dihydrotestosterone, and 17-beta estradiol, J Neurosci, 25, 4004, 10.1523/JNEUROSCI.5279-04.2005 Rosario, 2010, Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways, Brain Res, 1359, 281, 10.1016/j.brainres.2010.08.068 Leranth, 2003, Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats, J Neurosci, 23, 1588, 10.1523/JNEUROSCI.23-05-01588.2003 Azad, 2003, Testosterone treatment enhances regional brain perfusion in hypogonadal men, J Clin Endocrinol Metab, 88, 3064, 10.1210/jc.2002-020632 Cherrier, 2018, Changes in cerebral metabolic activity in men undergoing androgen deprivation therapy for non-metastatic prostate cancer, Prostate Cancer Prostatic Dis, 21, 394, 10.1038/s41391-018-0037-x Chao, 2013, Effects of androgen deprivation on cerebral morphometry in prostate cancer patients--an exploratory study, PloS One, 8, 10.1371/journal.pone.0072032 Akinola, 2018, Neuroanatomical and molecular correlates of cognitive and behavioural outcomes in hypogonadal males, Metab Brain Dis, 33, 491, 10.1007/s11011-017-0163-5 Buskbjerg, 2019, Testosterone supplementation and cognitive functioning in men-a systematic review and meta-analysis, J Endocr Soc, 3, 1465, 10.1210/js.2019-00119 Maki, 2009, Hormone therapy and cognitive function, Hum Reprod Update, 15, 667, 10.1093/humupd/dmp022 Foland-Ross, 2019, Androgen treatment effects on hippocampus structure in boys with Klinefelter syndrome, Psychoneuroendocrinology, 100, 223, 10.1016/j.psyneuen.2018.09.039 Harman, 2001, Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging, J Clin Endocrinol Metab, 86, 724, 10.1210/jcem.86.2.7219 Sherwin, 2003, Steroid hormones and cognitive functioning in aging men: a mini-review, J Mol Neurosci, 20, 385, 10.1385/JMN:20:3:385 Hsu, 2015, Longitudinal relationships between reproductive hormones and cognitive decline in older men: the Concord Health and Ageing in Men Project, J Clin Endocrinol Metab, 100, 2223, 10.1210/jc.2015-1016 Yaffe, 2002, Sex hormones and cognitive function in older men, J Am Geriatr Soc, 50, 707, 10.1046/j.1532-5415.2002.50166.x Wolf, 2000, Testosterone and cognition in elderly men: a single testosterone injection blocks the practice effect in verbal fluency, but has no effect on spatial or verbal memory, Biol Psychiatr, 47, 650, 10.1016/S0006-3223(99)00145-6 Cherrier, 2005, The role of aromatization in testosterone supplementation: effects on cognition in older men, Neurology, 64, 290, 10.1212/01.WNL.0000149639.25136.CA Cherrier, 2007, Characterization of verbal and spatial memory changes from moderate to supraphysiological increases in serum testosterone in healthy older men, Psychoneuroendocrinology, 32, 72, 10.1016/j.psyneuen.2006.10.008 Fonda, 2005, Age, hormones, and cognitive functioning among middle-aged and elderly men: cross-sectional evidence from the Massachusetts Male Aging Study, J Gerontol A Biol Sci Med Sci, 60, 385, 10.1093/gerona/60.3.385 LeBlanc, 2010, Osteoporotic Fractures in Men (MrOS) Research Group. Association between sex steroids and cognition in elderly men, Clin Endocrinol, 72, 393, 10.1111/j.1365-2265.2009.03692.x Yonker, 2006, Negative association of testosterone on spatial visualization in 35 to 80 year old men, Cortex, 42, 376, 10.1016/S0010-9452(08)70364-2 Geerlings, 2006, Endogenous sex hormones, cognitive decline, and future dementia in old men, Ann Neurol, 60, 346, 10.1002/ana.20918 Izard, 2020, Androgen deprivation therapy and mental health: impact on depression and cognition, Eur Urol Focus, 6, 1162, 10.1016/j.euf.2019.11.010 Green, 2002, Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial, BJU Int, 90, 427, 10.1046/j.1464-410X.2002.02917.x Almeida, 2004, One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men, Psychoneuroendocrinology, 29, 1071, 10.1016/j.psyneuen.2003.11.002 Alibhai, 2010, Levels of sex hormones have limited effect on cognition in older men with or without prostate cancer, Crit Rev Oncol Hematol, 73, 167, 10.1016/j.critrevonc.2009.03.005 Salminen, 2005, Estradiol and cognition during androgen deprivation in men with prostate carcinoma, Cancer, 103, 1381, 10.1002/cncr.20962 Beer, 2006, Testosterone loss and estradiol administration modify memory in men, J Urol, 175, 130 Jenkins, 2005, Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study, BJU Int, 96, 48, 10.1111/j.1464-410X.2005.05565.x Gunlusoy, 2017, Cognitive effects of androgen deprivation therapy in men with advanced prostate cancer, Urology, 103, 167, 10.1016/j.urology.2016.12.060 Tae, 2019, Correlation of androgen deprivation therapy with cognitive dysfunction in patients with prostate cancer: a nationwide population-based study using the national health insurance service database, Cancer Res Treat, 51, 593, 10.4143/crt.2018.119 Kang, 2020, Risk of dementia in prostate cancer survivors: a nationwide cohort study in Korea, Curr Probl Canc, 44, 100578, 10.1016/j.currproblcancer.2020.100578 Suissa, 2008, Immortal time bias in pharmaco-epidemiology, Am J Epidemiol, 167, 492, 10.1093/aje/kwm324 Kluger, 2020, Androgen deprivation therapy and cognitive function in prostate cancer, Curr Oncol Rep, 22, 24, 10.1007/s11912-020-0884-1 Lee, 2020, How does androgen deprivation therapy affect mental health including cognitive dysfunction in patients with prostate cancer?, World J Mens Health, 38 Gonzalez, 2015, Course and predictors of cognitive function in patients with prostate cancer receiving androgen deprivation therapy: A controlled comparison, J Clin Oncol, 33, 2021, 10.1200/JCO.2014.60.1963 Yang, 2015, Dissociation of event-based prospective memory and time-based prospective memory in patients with prostate cancer receiving androgen-deprivation therapy: a neuropsychological study, Eur J Canc Care, 24, 198, 10.1111/ecc.12299 Alibhai, 2017, Effects of long-term androgen deprivation therapy on cognitive function over 36 months in men with prostate cancer, Cancer, 123, 237, 10.1002/cncr.30320